Chronic exposure to low dose vanadium exacerbates the motor deficits in the Drosophila melanogaster PINK1 mutant model of Parkinson’s disease by Ohiomokhare SO et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Ohiomokhare SO, Ladagu A, Olapade J, Okello E, Chazot PL.  
Chronic exposure to low dose vanadium exacerbates the motor deficits in the 
Drosophila melanogaster PINK1 mutant model of Parkinson’s disease.  
In: BNA 2017 Festival of Neuroscience. 2017, Birmingham International 
Conference Centre: British Neuroscience Association. 
 
Copyright: 
This is the authors’ version of a paper that was presented at the BNA 2017 Festival of Neuroscience. 
Conference website: 
https://www.bna.org.uk/meetings/bna2017/ 
Date deposited:   
18/04/2017 
 
 Chronic exposure to low dose vanadium exacerbates the motor deficits in 
the Drosophila melanogaster PINK1 mutant model of Parkinson’s disease 
               S.O. Ohiomokhare,1  A. Ladagu2, J. Olopade2, E.Okello3  P.L. Chazot1. 
 
1Department of Biosciences, Durham University, UK; 2Environmental Toxicology and Neuroscience Unit, University of Ibadan,  
Nigeria; 3University of Newcastle, UK 
 
MATERIALS AND METHODS 
In vitro studies Catecholaminergic a-differentiated (CAD) neuronal cells were used for this study, as this cell line exhibits biochemical and morphological characteristics 
similar to primary dopaminergic neurons. It provides a useful tool for studying the effect of vanadium salts (in the form of sodium metavanadate) on early development using 
undifferentiated and differentiated cells (6 days post serum removal). Cell viability were investigated using the MTT Cell Proliferation  Assay.  
As a first step, a dose-dependent effect (1-500 µM of vanadium on the viability of CAD cells was investigated for 24h or 6 days. All values are mean ± SD for 4-6 replicates for 
at least n = 3 separate experiments). The association between iron and vanadium was investigated in the presence and absence of a synthetic iron chelator, Deferoxamine 
(DFO) Mesylate salt  (Sigma Aldrich) at 25, 50 and 100 µM as well as Aloysia citrodora palau (0.1mg/ml) essential oil, were investigated in the presence of different 
concentrations of vanadium.  
 
In vivo studies The PINK1 (w- PINK1B9/FM7.GFPw+  ) mutant and Wild type (WT) were used for this experiment. Flies were kept in an incubator with a 12h day-night cycle 
at 25oC. Fly food was prepared by mixing Applied Scientific Jazz-Mix Drosophila   Food (Fisher Scientific, Loughborough, UK). Appropriate amount of water was added to a 
measured feed (per bottle; 250mL Scientific Laboratory Supplies) and sodium metavanadate (1 µM, non-toxic dose). To prevent oxidation of L-Dopa, ascorbic acid was added 
to flasks containing L-Dopa .10 µM of synthetic iron chelator Deferoxamine (DFO) Mesylate salt  (Sigma Aldrich) was used. 
 
 
RESULTS 
                                                               INTRODUCTION  
Parkinson Disease (PD) is a progressive neurodegenerative movement disorders.  The PD pathology is characterised by distinct types of cellular defects; abnormal protein 
aggregation, oxidative damage, mitochondria dysfunction and a selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The PD brain SNpc has also 
been found to have higher levels of iron than age-matched controls, which has been associated with mitochondria dysfunction.  
Vanadium, a heavy metal, is found in many carbon containing deposits such as crude oil, coal, oil shale and tar. It is found in most soil as vanadate and are generally very soluble 
and taken up by plants at levels that reflect its availability.  As a heavy metal nutraceutical, vanadium has been used at low doses in different health supplement formulations. 
Environmental exposures to low dose vanadium can have deleterious effects on the population over extended periods. The effects of vanadium on Drosophila melanogaster PD 
model based on loss of function of Phosphatase and Tensin-induced Putative Kinase 1 (PINK1) was elucidated. Mutation in this gene has been identified in patients suffering from 
recessive Parkinsonism (1). This study is designed to explore the interplay between vanadium with iron in an in vitro (Catecholaminergic a-differentiated (CAD) cells) and an in vivo 
model (PINK1 mutant). This mutant displays muscle degeneration, hypersensitivity to oxidative stress, mitochondria defects, reduced life span, dopamine neuronal degeneration 
and locomotor defects. The predisposition of this mutant and wild type  to low dose of vanadium as well as the interplay between vanadium with iron in neurons was elucidated. 
Furthermore we investigate how these effects can be ameliorated using a synthetic (Deferoxamine Mesylate) and natural essential oil (Aloysia citrodora) iron chelator. 
 
                                     CONCLUSIONS & FUTURE DIRECTIONS 
• These findings provide new evidence for the potential differential effects of  vanadium in the healthy population and Parkinson’s disease  sufferers, and 
protection by iron chelation 
• This highlights the need for caution in using vanadium health supplements in individuals with neurodegenerative disease.  
• Furthermore, these findings also offer a new therapeutic option (Aloysia citrodora) for combatting the toxic effects of chronic exposure to vanadium 
accumulation in heavily polluted regions of the world. 
 
Figure 1:Effects of vanadium upon viability of CAD  cells: Influence of Iron 
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Differentiated CAD cells (A) was insensitive to vanadium following a short-term 24h exposure. In contrast, long-term exposure (6 days) to >200 μM vanadium 
elicits significant neurotoxicity in differentiating CAD cells (B) **p<0.01 Vs control, which was ameliorated with an iron chelator, Deferoxamine (DFO) and 
Aloysia citrodora (C) *p<0.05 Vs PBS + vanadium. All values are mean ± SD for 4-6 replicates for at least n = 3 separate experiments).  
A progressive decrease in the locomotor activity and life span of the flies exposed to vanadium over time was observed across the three groups tested; in the WT (A & 
C) and PINK1 mutant  (B & D) respectively. Notably, while exposure of PINK1 mutant to vanadium significantly exacerbated existing locomotor deficits,  a slight 
improvement was observed with WT. A moderate improvement was observed in the locomotor activity in the presence of the iron chelator (DFO) following chronic 
exposure to vanadium (E) 
Figure 2: Effects of low dose vanadium on locomotor activity and life span in Drosophila melanogaster: influence of iron  
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